These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 28323826)

  • 21. Association of APOE ε4 genotype and lifestyle with cognitive function among Chinese adults aged 80 years and older: A cross-sectional study.
    Jin X; He W; Zhang Y; Gong E; Niu Z; Ji J; Li Y; Zeng Y; Yan LL
    PLoS Med; 2021 Jun; 18(6):e1003597. PubMed ID: 34061824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study.
    Slooter AJ; Cruts M; Kalmijn S; Hofman A; Breteler MM; Van Broeckhoven C; van Duijn CM
    Arch Neurol; 1998 Jul; 55(7):964-8. PubMed ID: 9678314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accelerated progression from mild cognitive impairment to dementia among APOE ε4ε4 carriers.
    Xu WL; Caracciolo B; Wang HX; Santoni G; Winblad B; Fratiglioni L
    J Alzheimers Dis; 2013; 33(2):507-15. PubMed ID: 23247007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution and clinical impact of apolipoprotein E4 in subjective memory impairment and early mild cognitive impairment.
    Cho H; Kim YE; Chae W; Kim KW; Kim JW; Kim HJ; Na DL; Ki CS; Seo SW
    Sci Rep; 2020 Aug; 10(1):13365. PubMed ID: 32770103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dementia Incidence,
    Lavrencic LM; Delbaere K; Broe GA; Daylight G; Draper B; Cumming RG; Garvey G; Allan W; Hill TY; Lasschuit D; Schofield PR; Radford K
    Neurology; 2022 Mar; 98(11):e1124-e1136. PubMed ID: 35140131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies.
    Hadjichrysanthou C; McRae-McKee K; Evans S; de Wolf F; Anderson RM;
    J Alzheimers Dis; 2018; 66(2):587-600. PubMed ID: 30320573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele.
    Caselli RJ; Reiman EM; Osborne D; Hentz JG; Baxter LC; Hernandez JL; Alexander GG
    Neurology; 2004 Jun; 62(11):1990-5. PubMed ID: 15184602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid.
    Rosenberg A; Solomon A; Jelic V; Hagman G; Bogdanovic N; Kivipelto M
    Alzheimers Res Ther; 2019 Dec; 11(1):99. PubMed ID: 31805990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
    Smith R; Strandberg O; Mattsson-Carlgren N; Leuzy A; Palmqvist S; Pontecorvo MJ; Devous MD; Ossenkoppele R; Hansson O
    Brain; 2020 Dec; 143(12):3805-3815. PubMed ID: 33439987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of Cognitive Decline for Enrichment of Alzheimer's Disease Clinical Trials.
    Tam A; Laurent C; Gauthier S; Dansereau C
    J Prev Alzheimers Dis; 2022; 9(3):400-409. PubMed ID: 35841241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of APOE and a polygenic risk score on incident dementia and cognitive decline in a healthy older population.
    Riaz M; Huq A; Ryan J; Orchard SG; Tiller J; Lockery J; Woods RL; Wolfe R; Renton AE; Goate AM; Sebra R; Schadt E; Brodtmann A; Shah RC; Storey E; Murray AM; McNeil JJ; Lacaze P
    Aging Cell; 2021 Jun; 20(6):e13384. PubMed ID: 34041846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample.
    Tilvis RS; Strandberg TE; Juva K
    J Am Geriatr Soc; 1998 Jun; 46(6):712-5. PubMed ID: 9625186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations of Amyloid, Tau, and Neurodegeneration Biomarker Profiles With Rates of Memory Decline Among Individuals Without Dementia.
    Jack CR; Wiste HJ; Therneau TM; Weigand SD; Knopman DS; Mielke MM; Lowe VJ; Vemuri P; Machulda MM; Schwarz CG; Gunter JL; Senjem ML; Graff-Radford J; Jones DT; Roberts RO; Rocca WA; Petersen RC
    JAMA; 2019 Jun; 321(23):2316-2325. PubMed ID: 31211344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort.
    Chen Y; Denny KG; Harvey D; Farias ST; Mungas D; DeCarli C; Beckett L
    Alzheimers Dement; 2017 Apr; 13(4):399-405. PubMed ID: 27590706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alcohol Consumption and Risk of Dementia and Cognitive Decline Among Older Adults With or Without Mild Cognitive Impairment.
    Koch M; Fitzpatrick AL; Rapp SR; Nahin RL; Williamson JD; Lopez OL; DeKosky ST; Kuller LH; Mackey RH; Mukamal KJ; Jensen MK; Sink KM
    JAMA Netw Open; 2019 Sep; 2(9):e1910319. PubMed ID: 31560382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Variation in the Ontario Neurodegenerative Disease Research Initiative.
    Dilliott AA; Evans EC; Farhan SMK; Ghani M; Sato C; Zhang M; McIntyre AD; Cao H; Racacho L; Robinson JF; Strong MJ; Masellis M; Bulman DE; Rogaeva E; Black SE; Finger E; Frank A; Freedman M; Hassan A; Lang A; Shoesmith CL; Swartz RH; Tang-Wai D; Tartaglia MC; Turnbull J; Zinman L; ; Hegele RA
    Can J Neurol Sci; 2019 Sep; 46(5):491-498. PubMed ID: 31217043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mild Cognitive Impairment that Does Not Progress to Dementia: A Population-Based Study.
    Ganguli M; Jia Y; Hughes TF; Snitz BE; Chang CH; Berman SB; Sullivan KJ; Kamboh MI
    J Am Geriatr Soc; 2019 Feb; 67(2):232-238. PubMed ID: 30444944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for transitions from normal to mild cognitive impairment and dementia.
    Kryscio RJ; Schmitt FA; Salazar JC; Mendiondo MS; Markesbery WR
    Neurology; 2006 Mar; 66(6):828-32. PubMed ID: 16567698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apolipoprotein E alleles in Cuban patients with mild cognitive impairment.
    Suárez VM; Fernández Y; López Edel C; Clarke DH; Bobes MA; Riverón AM; López-Cánovas L
    Am J Alzheimers Dis Other Demen; 2014 May; 29(3):236-41. PubMed ID: 24370622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.